Dexmedetomine vs Dexamethasone in TAB Block for Abdominal Surgries
NCT ID: NCT05323565
Last Updated: 2022-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
45 participants
INTERVENTIONAL
2022-04-01
2022-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexamethasone Versus Dexmedetomidine
NCT03064633
Compare Intraperitoneal Instillation of Bupivacaine+dexmedetomidine Versus Bupivacaine+dexamethasone on Postoperative Pain After Lap Cholecystectomy
NCT06535256
Dexmedetomidine As an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries
NCT06453681
Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block
NCT03778671
Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block
NCT06624319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (n=15): (Dexamethasone group)
Patients will receive 20 ml 0.25% bupivacaine plus 4 mg dexamethasone on each side TAB bock.
Dexmedetomidine
adjuvants to 0.25 bupivacaine in TAB block.
Group B (n=15): (Dexmedetomidine group)
Patients will receive 20 ml 0.25% bupivacaine plus 0.5 mcg/kg of dexmedetomidine on each side TAB block.
Dexmedetomidine
adjuvants to 0.25 bupivacaine in TAB block.
Group C (n=15): (control group)
Patients will receive 20 ml 0.25% bupivacaine on each side TAB block.
Dexmedetomidine
adjuvants to 0.25 bupivacaine in TAB block.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
adjuvants to 0.25 bupivacaine in TAB block.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient refusal.
* Psychiatric or physical illness that lead to inability to cooperate, speak or read.
* Abdominal operations under spinal anesthesia.
* History or evidence of coagulopathy.
* Known allergies to drugs used .
* Preexisting neurological disorders.
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasser Sayed Sobhy
Anesthesia specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasser Sayed, Master
Role: PRINCIPAL_INVESTIGATOR
Ain Shams University, Faculty of medecine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University, Faculty of medicine
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU M D 184/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.